Impact of COVID-19 pandemic on bariatric surgery in India: An obesity and metabolic surgery society of India survey of 1307 patients

Autor: Aparna Govil Bhasker, Manish Khaitan, Vivek Bindal, Amardeep Kumar, Anirudh Rajkumar, Anshuman Kaushal, Arun Prasad, Chirag Parikh, Daksh Sethi, Deep Goel, Deepak Thampi Hareendran, Digvijay Bedi, Gurvinder Singh Jammu, Jayanth Leo, Kuldeepak Kular, Mahendra Narwaria, Mahesh Chikkachanappa, Manish Motwani, Manoj Bharucha, Mohamed Ismail, Nandkishore Dukkipati, Neha Shah, Om Tantia, Parag Patel, R Padmakumar, Rahul Singh, Raj Palaniappan, Rajesh Shrivastava, Ram Raksha Pal Rajput, Ramen Goel, Randeep Wadhawan, Rohit Garg, Sandeep Aggarwal, Sanjay Patolia, Sarfaraz J Baig, Shashank Shah, H V Shivaram, Shrihari Dhorepatil, Sukhvinder Singh Saggu, Surendra Ugale, T Perungo, Vandana Soni
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Journal of Minimal Access Surgery, Vol 17, Iss 4, Pp 542-547 (2021)
Druh dokumentu: article
ISSN: 0972-9941
1998-3921
DOI: 10.4103/jmas.JMAS_2_21
Popis: Background: Although safe practice guidelines were issued by the Obesity and Metabolic Surgery Society of India (OSSI) in the end of May 2020, surgeons have been in a dilemma about risk of subjecting patients to hospitalisation and bariatric surgery. This survey was conducted with the objective to evaluate the risk of coronavirus disease-19 (COVID-19) infection in peri- and post-operative period after bariatric and metabolic surgery (BMS). Methods: A survey with OSSI members was conducted from 20 July 2020 to 31 August 2020 in accordance with EQUATOR guidelines. Google Form was circulated to all surgeon members through E-mail and WhatsAppTM. In the second phase, clinical details were captured from surgeons who reported positive cases. Results: One thousand three hundred and seven BMS were reported from 1 January 2020 to 15 July 2020. Seventy-eight per cent were performed prior to 31 March 2020 and 276 were performed after 1 April 2020. Of these, 13 (0.99%) patients were reported positive for COVID-19 in the post-operative period. All suffered from a mild disease and there was no mortality. Eighty-seven positive cases were reported from patients who underwent BMS prior to 31 December 2019. Of these, 82.7% of patients had mild disease, 13.7% of patients had moderate symptoms and four patients succumbed to COVID-19. Conclusion: BMS may be considered as a safe treatment option for patients suffering from clinically severe obesity during the COVID-19 pandemic. Due care must be taken to protect patients and healthcare workers and all procedures must be conducted in line with the safe practice guidelines.
Databáze: Directory of Open Access Journals
Externí odkaz: